Show simple item record

dc.contributor.authorPapadopoulou, MVen_US
dc.contributor.authorBloomer, WDen_US
dc.contributor.authorRosenzweig, HSen_US
dc.contributor.authorWILKINSON, SRen_US
dc.contributor.authorSzular, Jen_US
dc.contributor.authorKaiser, Men_US
dc.date.accessioned2016-04-14T08:28:38Z
dc.date.available2016-04-05en_US
dc.date.issued2016-07-19en_US
dc.date.submitted2016-04-07T15:05:22.552Z
dc.identifier.issn0223-5234en_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/11848
dc.description.abstractA small series of 5-nitro-2-aminothiazole-based amides containing arylpiperazine-, biphenyl- or aryloxyphenyl groups in their core were synthesized and evaluated as anti-trypanosomatid agents. All tested compounds were active or moderately active against Trypanosoma cruzi amastigotes in infected L6 cells and Trypanosoma brucei brucei, four were moderately active against Leishmania donovani axenic parasites while none were deemed active against Trypanosoma brucei rhodesiense. For the most active/moderately active compounds a moderate selectivity against the human infectious parasites was observed. There was a good correlation between lipophilicity (clogP value) versus antileishmanial activity and mammalian cell toxicity with a similar correlation also noted between clogP values and IC50 values against T. cruzi in structurally related subgroups of compounds. Three compounds were more potent as antichagasic agents than benznidazole.en_US
dc.description.sponsorshipThis work was supported in part by internal funds of the Radiation Medicine Department at NorthShore University HealthSystem. In addition, the Drugs for Neglected Diseases initiative (DNDi) received financial support from the Bill and Melinda Gates Foundation to perform the in vitro screenings against parasites.en
dc.format.extent179 - 186 (8)en_US
dc.language.isoenen
dc.publisherElsevieren_US
dc.relation.ispartofEuropean Journal of Medicinal Chemistryen_US
dc.rights© 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titleAntitrypanosomal activity of 5-nitro-2-aminothiazole-based compoundsen_US
dc.typeArticle
dc.rights.holderCopyright © 2016 Published by Elsevier Masson SAS
dc.identifier.doi10.1016/j.ejmech.2016.04.010en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.publisher-urlhttp://dx.doi.org/10.1016/j.ejmech.2016.04.010en_US
pubs.volume117en_US
dcterms.dateAccepted2016-04-05en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record